Search results
Results from the WOW.Com Content Network
eBioMedicine is a peer-reviewed open access medical journal initially launched by Elsevier, shortly thereafter supported by Cell Press and The Lancet, and in 2018 incorporated in The Lancet family journals, at the occasion of the inception of its sister journal eClinicalMedicine (Impact Factor 17.033), also published by The Lancet. [1]
Fang Zheng Peng is the Director, Energy GRID Institute and a RK Mellon Endowed Chair Professor of Electrical and Computer Engineering in the University of Pittsburgh, U.S. [1] [2] Earlier, he was a Distinguished Professor of Engineering at the Center for Advanced Power Systems, Florida State University, U.S. [3] His primary research area is power electronics, covering the development of Z ...
LinkedIn Learning is an American online learning platform. It provides video courses taught by industry experts in software, creative, and business skills. It is a subsidiary of LinkedIn. All the courses on LinkedIn fall into four categories: Business, Creative, Technology, and Certifications.
Peng earned a master's degree in probability theory and mathematical statistics from the University of Science and Technology of China. [2] She completed her Ph.D. at the University of Wisconsin–Madison in 2005. Her dissertation, Contributions to Semi-Competing Risks Data, was jointly supervised by Rick Chappell and Jason Fine. [3]
Feng Zhang (Chinese: 张锋; pinyin: Zhāng Fēng; born October 22, 1981) is a Chinese–American biochemist.Zhang currently holds the James and Patricia Poitras Professorship in Neuroscience at the McGovern Institute for Brain Research and in the departments of Brain and Cognitive Sciences and Biological Engineering at the Massachusetts Institute of Technology.
Zhang Tingdong (Chinese: 张亭栋; pinyin: Zhāng Tíngdòng; born on November 8, 1932) is a Chinese medical scientist, pharmaceutical chemist, and educator at Harbin Medical University, 1st affiliated Hospital, and is best known for discovering of using arsenic trioxide to treat leukemia, which is regarded as a significant breakthrough of anti-leukemia medicine in the 20th Century and ...
Roger D. Peng is an author and professor of Statistics and Data Science at the University of Texas at Austin. [1] [2] Peng originally received a Bachelor of Science in Applied Mathematics from Yale University in 1999, before going on to study at the University of California, Los Angeles, where he completed a Master of Science in Statistics in 2001 and a PhD in Statistics in 2003.
Peng Zhao was a summer associate at Lehman Brothers and was a quantitative researcher at Evnine & Associates before joining Citadel. [5] Peng Zhao joined Citadel Securities in 2006 as a quantitative researcher. [6] In July 2016, Citadel Securities announced that then Microsoft COO, B. Kevin Turner, was joining the firm as CEO. [7]